L02BX Other hormone antagonists and related agents

PheWeb

RX_L02BX

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L02BX

959

Check pre-conditions, main-only, mode, ICD version None

771

Check minimum number of events

Min. number of events 3

771

Include endpoints None

771

RX_L02BX

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L02BX Other hormone antagonists and related agents based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	742	-	742
Unadjusted prevalence (%)	0.24	-	0.55
Mean age at first event (years)	72.42	-	72.42

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BX – L02BX Other hormone antagonists and related agents
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BX Other hormone antagonists and related agents
after L02BX Other hormone antagonists and related agents

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L02BX Other hormone antagonists and related agents

↥